Výsledky vyhledávání - "Toni Rachocki"

The role of cetuximab in induction chemotherapy: Comparison of APF-C (nab-paclitaxel, cisplatin, 5-FU + cetuximab) with APF, both followed by chemoradiation therapy (CRT), in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)

Autor: Douglas Adkins, Jessica C. Ley, Tanya Marya Wildes, Loren S. Michel, Jason Rich, Randal Paniello, Ravi Uppaluri, Wade L. Thorstad, Hiram Alberto Gay, Kathryn Trinkaus, Toni Rachocki, Brian Nussenbaum

Publikováno v: Journal of Clinical Oncology. 33:6042-6042

6042 Background: Cetuximab (C) improved overall survival (OS) in patients (pts) with HNSCC when added to definitive RT or to palliative chemotherapy; however, the role of cetuximab in induction che...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9c11963f654c8dbdd2dd3e5d24ab8cb
https://doi.org/10.1200/jco.2015.33.15_suppl.6042

Zobrazit plný text záznamu

Comparison of clinical primary tumor site (PTS) response to induction chemotherapy (IC) with APF (nab-paclitaxel, cisplatin, and 5-FU) or APF plus cetuximab (APF+Cetux) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Autor: Jessica C. Ley, Brian Nussenbaum, Jason Diaz, Jason Rich, Randal Paniello, Ravi Uppaluri, Wade L. Thorstad, Hiram Alberto Gay, Toni Rachocki, Jaisy Varges, Tanya Marya Wildes, Loren S. Michel, Douglas Adkins

Publikováno v: Journal of Clinical Oncology. 32:6013-6013

6013 Background: Achievement of a favorable (> PR) response (particularly CR) at the PTS to IC predicts a higher likelihood of long-term disease control after definitive chemoradiotherapy (CRT) in ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1d784497e97035b5d0a6aa15f547a3d8
https://doi.org/10.1200/jco.2014.32.15_suppl.6013

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání